Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 87001-87050 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT05327933
Preventing Recurrences of Chronic Subdural Hematoma in Adult Patients by Middle Meningeal Artery Embolization
NA
Recruiting
154 participants
Started: May 26, 2022 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT05317494
A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy Receiving Oral Venetoclax Tablets in Greece
N/A
Recruiting
100 participants
Started: May 26, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
13 locations
NCT05412680
Transoral Endoscopic Thyroidectomy by Vestibular Approach (TOETVA)
NA
Recruiting
60 participants
Started: May 25, 2022 · Completed: Dec 31, 2024
2 conditions
1 sponsor
1 location
NCT04863950
Investigator-Initiated Study of Imipramine Hydrochloride and Lomustine in Recurrent Glioblastoma
PHASE2
Recruiting
25 participants
Started: May 25, 2022 · Completed: Nov 30, 2026
1 condition
1 sponsor
1 location
NCT05763940
Efficacy of OmegaBoost to Increase Omega-3 Levels in Healthy Individuals
NA
Active, not recruiting
130 participants
Started: May 25, 2022 · Completed: Jun 25, 2024
3 conditions
2 sponsors
1 location
NCT05301764
A Study of LVGN6051 Combined with Anlotinib in Patient with Soft Tissue Sarcoma
PHASE1/PHASE2
Recruiting
65 participants
Started: May 25, 2022 · Completed: Oct 19, 2025
1 condition
1 sponsor
5 locations
NCT05307289
Study of Alterations in Tumor Metabolism Associated With the Development of Immunotherapy Resistance in Melanoma
NA
Recruiting
20 participants
Started: May 25, 2022 · Completed: Oct 25, 2028
1 condition
1 sponsor
1 location
NCT05060289
A Prognostic Model for Drug-induced Liver Injury in China
N/A
Recruiting
3,000 participants
Started: May 25, 2022 · Completed: Dec 31, 2028
1 condition
1 sponsor
13 locations
NCT04961190
A Comparison of Prolonged Exposure Therapy, Pharmacotherapy, and Their Combination for PTSD
PHASE4
Recruiting
300 participants
Started: May 25, 2022 · Completed: Jul 15, 2026
1 condition
9 sponsors
7 locations
NCT05277714
Neurofeedback Based on Near-infrared Spectroscopy as a Therapy for Food Addiction in Obese Subjects.
NA
Recruiting
50 participants
Started: May 25, 2022 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT05342584
Venetoclax Plus Intensive Chemotherapy in AML and Advanced MDS
PHASE1
Recruiting
99 participants
Started: May 25, 2022 · Completed: Dec 31, 2028
2 conditions
2 sponsors
1 location
NCT05387473
Added Value of Cognitive Behavioural Therapy for Insomnia in Persons With Knee Osteoarthritis
NA
Active, not recruiting
128 participants
Started: May 25, 2022 · Completed: Nov 30, 2026
2 conditions
3 sponsors
1 location
NCT05333003
Semaglutide in Comorbid Schizophrenia Spectrum Disorder and Obesity
NA
Recruiting
92 participants
Started: May 25, 2022 · Completed: Aug 31, 2025
1 condition
1 sponsor
1 location
NCT05185492
Multi-center Collaborative to Enhance Quality and Outcomes in the Management of Cardiogenic Shock
N/A
Recruiting
500 participants
Started: May 25, 2022 · Completed: Dec 31, 2027
2 conditions
1 sponsor
3 locations
NCT05356104
GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAPP-SVD)
PHASE2
Recruiting
110 participants
Started: May 25, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05052671
ctDNA Assay in Patients With Resectable Pancreatic Cancer
N/A
Recruiting
50 participants
Started: May 25, 2022 · Completed: Dec 31, 2027
1 condition
2 sponsors
2 locations
NCT05519046
Cardiac Contractility Modulation in Chagas Heart Disease
NA
Recruiting
60 participants
Started: May 25, 2022 · Completed: Dec 31, 2026
5 conditions
3 sponsors
1 location
NCT05328856
Effects of Vital Shower on Quality of Life, Immune Function, Cardiovascular Regulation and Well-being
NA
Recruiting
50 participants
Started: May 25, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT06180876
Effect of Remimazolam on Postoperative Delirium
NA
Recruiting
190 participants
Started: May 25, 2022 · Completed: Jan 30, 2024
1 condition
1 sponsor
1 location
NCT05778032
Biological Age Assessment in Adults With Prader-Willi Syndrome (ETABIOLPWS)
N/A
Active, not recruiting
30 participants
Started: May 25, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05472259
A Study Evaluating the Efficacy of 5-FU + NALIRI and 5-FU + NALIRINOX for PDAC (NALPAC)
PHASE2
Recruiting
134 participants
Started: May 25, 2022 · Completed: Dec 31, 2027
1 condition
2 sponsors
13 locations
NCT04752137
Intraoperative Tumor Margin Identification With ICG Dye Imaging
PHASE2
Recruiting
100 participants
Started: May 25, 2022 · Completed: Oct 1, 2026
2 conditions
1 sponsor
1 location
NCT06284473
Ketamine as a Supplement to Local Anesthesia for Minor Procedures
PHASE4
Recruiting
108 participants
Started: May 25, 2022 · Completed: May 31, 2028
3 conditions
1 sponsor
1 location
NCT05434234
A Study of YL201 in Patients With Advanced Solid Tumors
PHASE1/PHASE2
Recruiting
312 participants
Started: May 25, 2022 · Completed: Oct 6, 2027
1 condition
1 sponsor
45 locations
NCT05144087
The Influence of Mepolizumab on Structural and Inflammatory Cells in Severe Eosinophilic Asthma
N/A
Active, not recruiting
18 participants
Started: May 25, 2022 · Completed: Nov 30, 2027
1 condition
3 sponsors
1 location
NCT04629547
Sleep Trial to Prevent Alzheimer's Disease
PHASE2
Recruiting
200 participants
Started: May 25, 2022 · Completed: May 31, 2026
2 conditions
3 sponsors
1 location
NCT06866301
Active Lifestyle Intervention in Anorexia Nervosa: a Comprehensive Study
NA
Active, not recruiting
48 participants
Started: May 25, 2022 · Completed: Nov 30, 2025
1 condition
1 sponsor
1 location
NCT06063928
Confronting Cancer as a Community
N/A
Recruiting
500 participants
Started: May 25, 2022 · Completed: May 25, 2028
1 condition
2 sponsors
2 locations
NCT06874894
Thromboembolic And Bleeding Risks During anticoaGulant trEatment in Asian paTients With Atrial Fibrillation (TARGET-AF)
N/A
Enrolling by invitation
1,100 participants
Started: May 25, 2022 · Completed: Aug 30, 2026
1 condition
7 sponsors
1 location
NCT06770621
Longitudinal Study of the GLUcagon REsponse to Hypoglycemia in Children and Adolescents With New-onset Type 1 DIAbetes
NA
Recruiting
1,000 participants
Started: May 25, 2022 · Completed: Oct 25, 2025
2 conditions
2 sponsors
1 location
NCT04423874
The Effect of Exposure to Aversive Non-verbal Vocalizations on Pain Tolerance
NA
Recruiting
104 participants
Started: May 25, 2022 · Completed: May 31, 2026
1 condition
2 sponsors
1 location
NCT05356377
Preliminary Study of Brain Effects of Palynziq-Related Changes in Phenylalanine in Individuals With PKU
N/A
Enrolling by invitation
13 participants
Started: May 25, 2022 · Completed: Dec 31, 2025
1 condition
2 sponsors
2 locations
NCT04968015
Venetoclax + Cytarabine Versus Idarubicin + Cytarabine : Efficacity Assessment as Post-remission Therapy to Elderly Patients With Acute Myeloid Leukemia in First Remission
PHASE2
Active, not recruiting
134 participants
Started: May 25, 2022 · Completed: Jan 31, 2029
1 condition
1 sponsor
26 locations
NCT05370547
Chidamide Bridging for CAR-T Therapy
PHASE1/PHASE2
Recruiting
120 participants
Started: May 25, 2022 · Completed: Jun 30, 2025
1 condition
1 sponsor
13 locations
NCT05430178
Metabolic Pathology of Pediatric NAFLD
NA
Recruiting
100 participants
Started: May 25, 2022 · Completed: Jun 30, 2026
3 conditions
2 sponsors
1 location
NCT05392699
ABOD2011 in Patients With Advanced Solid Tumors Progressed After Standard Systemic Therapy
PHASE1
Recruiting
60 participants
Started: May 25, 2022 · Completed: Jan 31, 2027
1 condition
1 sponsor
1 location
NCT05967169
EFS of Bioabsorbable Implant for NSD
NA
Active, not recruiting
30 participants
Started: May 25, 2022 · Completed: Dec 8, 2025
1 condition
1 sponsor
2 locations
NCT05449106
Evaluation of Clinical Outcomes of Unruptured bAVMs Treated With Medical Management Alone Based on Multimodal CT
N/A
Recruiting
200 participants
Started: May 25, 2022 · Completed: May 25, 2032
1 condition
4 sponsors
4 locations
NCT05518383
B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021
PHASE4
Recruiting
300 participants
Started: May 25, 2022 · Completed: May 16, 2027
5 conditions
1 sponsor
1 location
NCT05147961
Precision Medicine for Preventing Type 2 Diabetes: a Step Forward
NA
Recruiting
300 participants
Started: May 25, 2022 · Completed: Apr 1, 2025
1 condition
3 sponsors
2 locations
NCT04517656
Biomarkers Impact Evaluation on the Post-transplant Immune Response After Allografting of Hematopoietic Stem Cells
NA
Recruiting
40 participants
Started: May 25, 2022 · Completed: Sep 30, 2026
1 condition
3 sponsors
1 location
NCT05329935
Congenital Athymia Patient Registry
N/A
Recruiting
75 participants
Started: May 25, 2022 · Completed: Apr 30, 2026
3 conditions
1 sponsor
1 location
NCT05355025
WiserAD: The Effect of a Structured Online Intervention on Antidepressant Deprescribing in Primary Care
NA
Recruiting
312 participants
Started: May 25, 2022 · Completed: Aug 7, 2025
1 condition
2 sponsors
1 location
NCT05338775
A Study of Talquetamab and Teclistamab Each in Combination With a Programmed Cell Death Receptor-1 (PD-1) Inhibitor for the Treatment of Participants With Relapsed or Refractory Multiple Myeloma
PHASE1
Active, not recruiting
74 participants
Started: May 25, 2022 · Completed: May 3, 2027
1 condition
1 sponsor
19 locations
NCT06148285
Hyperbaric Oxygen Therapy in Acute Ischemic Stroke Ischemic Stroke Recovery (Pro00061930)
NA
Recruiting
120 participants
Started: May 24, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05431257
Azacitidine in Combination With Low Dose Intensity Venetoclax in Patients With AML Incl. Explorative AML Profiling
PHASE2
Recruiting
117 participants
Started: May 24, 2022 · Completed: Sep 1, 2031
1 condition
14 sponsors
1 location
NCT05199584
A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
PHASE2
Active, not recruiting
44 participants
Started: May 24, 2022 · Completed: May 31, 2024
1 condition
1 sponsor
16 locations
NCT06328179
Clinical Study Protocol for the Treatment of ND-AML and RR-AML With KMT2A Gene Abnormalities Using VHEA.
NA
Recruiting
34 participants
Started: May 24, 2022 · Completed: Dec 30, 2027
1 condition
4 sponsors
1 location
NCT05397223
A Study of Modified mRNA Vaccines in Healthy Adults
PHASE1
Active, not recruiting
308 participants
Started: May 24, 2022 · Completed: Feb 21, 2026
4 conditions
1 sponsor
8 locations
NCT04282473
Peristomal Hernia Rate 5 Years After a Terminal Colostomy With the Parietex ™ TCM Parietal Prosthesis Versus Without Mesh
N/A
Recruiting
134 participants
Started: May 24, 2022 · Completed: May 31, 2026
2 conditions
1 sponsor
16 locations
Previous
1
More pages
1738
1739
1740
1741
1742
1743
1744
More pages
2369
Next